Clinical Trial Update: Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population

View source ↗

Summary

This completed clinical trial evaluated the safety of GlaxoSmithKline's Hepatitis A vaccine in a Korean population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Havrix (hepatitis A vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A | Status: COMPLETED